Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
All India Institute of Medical Sciences, India
Breast cancer patient therapeutic response monitored by proton MR spectroscopy
October 13th, 2006
The therapeutic response of breast cancer patients could be monitored by in vivo proton (H-1) MR spectroscopy (MRS). According to a recent article published in the Journal of Magnetic Resonance Imaging, scientists in India conducted a study "to evaluate the use of the water-to-fat (W-F) value obtained from in vivo proton (H-1) MR spectroscopy (MRS) as a response indicator of cytologically confirmed patients with locally advanced breast cancer (LABC), and to monitor the therapeutic response of such patients to neoadjuvant chemotherapy (NACT)." "Serial H-1 MR spectra were recorded both before and after the completion of chemotherapy in 33 LABC...
Source: Medicine & Law Weekly (2006-10-13)
|
